Copyright Reports & Markets. All rights reserved.

Global In situ Hybridization Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global In situ Hybridization Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Fluorescence In Situ Hybridization (FISH)
      • 1.4.3 Chromogenic In Situ Hybridization
    • 1.5 Market by Application
      • 1.5.1 Global In situ Hybridization Market Share by Application (2014-2025)
      • 1.5.2 Cancer Diagnosis
      • 1.5.3 Immunology
      • 1.5.4 Neuroscience
      • 1.5.5 Cytology
      • 1.5.6 Infectious Diseases
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 In situ Hybridization Market Size
    • 2.2 In situ Hybridization Growth Trends by Regions
      • 2.2.1 In situ Hybridization Market Size by Regions (2014-2025)
      • 2.2.2 In situ Hybridization Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 In situ Hybridization Market Size by Manufacturers
      • 3.1.1 Global In situ Hybridization Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global In situ Hybridization Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global In situ Hybridization Market Concentration Ratio (CR5 and HHI)
    • 3.2 In situ Hybridization Key Players Head office and Area Served
    • 3.3 Key Players In situ Hybridization Product/Solution/Service
    • 3.4 Date of Enter into In situ Hybridization Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global In situ Hybridization Market Size by Type (2014-2019)
    • 4.2 Global In situ Hybridization Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States In situ Hybridization Market Size (2014-2019)
    • 5.2 In situ Hybridization Key Players in United States
    • 5.3 United States In situ Hybridization Market Size by Type
    • 5.4 United States In situ Hybridization Market Size by Application

    6 Europe

    • 6.1 Europe In situ Hybridization Market Size (2014-2019)
    • 6.2 In situ Hybridization Key Players in Europe
    • 6.3 Europe In situ Hybridization Market Size by Type
    • 6.4 Europe In situ Hybridization Market Size by Application

    7 China

    • 7.1 China In situ Hybridization Market Size (2014-2019)
    • 7.2 In situ Hybridization Key Players in China
    • 7.3 China In situ Hybridization Market Size by Type
    • 7.4 China In situ Hybridization Market Size by Application

    8 Japan

    • 8.1 Japan In situ Hybridization Market Size (2014-2019)
    • 8.2 In situ Hybridization Key Players in Japan
    • 8.3 Japan In situ Hybridization Market Size by Type
    • 8.4 Japan In situ Hybridization Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia In situ Hybridization Market Size (2014-2019)
    • 9.2 In situ Hybridization Key Players in Southeast Asia
    • 9.3 Southeast Asia In situ Hybridization Market Size by Type
    • 9.4 Southeast Asia In situ Hybridization Market Size by Application

    10 India

    • 10.1 India In situ Hybridization Market Size (2014-2019)
    • 10.2 In situ Hybridization Key Players in India
    • 10.3 India In situ Hybridization Market Size by Type
    • 10.4 India In situ Hybridization Market Size by Application

    11 Central & South America

    • 11.1 Central & South America In situ Hybridization Market Size (2014-2019)
    • 11.2 In situ Hybridization Key Players in Central & South America
    • 11.3 Central & South America In situ Hybridization Market Size by Type
    • 11.4 Central & South America In situ Hybridization Market Size by Application

    12 International Players Profiles

    • 12.1 Abbott Laboratories
      • 12.1.1 Abbott Laboratories Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 In situ Hybridization Introduction
      • 12.1.4 Abbott Laboratories Revenue in In situ Hybridization Business (2014-2019)
      • 12.1.5 Abbott Laboratories Recent Development
    • 12.2 Roche
      • 12.2.1 Roche Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 In situ Hybridization Introduction
      • 12.2.4 Roche Revenue in In situ Hybridization Business (2014-2019)
      • 12.2.5 Roche Recent Development
    • 12.3 Thermo Fisher Scientific
      • 12.3.1 Thermo Fisher Scientific Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 In situ Hybridization Introduction
      • 12.3.4 Thermo Fisher Scientific Revenue in In situ Hybridization Business (2014-2019)
      • 12.3.5 Thermo Fisher Scientific Recent Development
    • 12.4 Merck
      • 12.4.1 Merck Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 In situ Hybridization Introduction
      • 12.4.4 Merck Revenue in In situ Hybridization Business (2014-2019)
      • 12.4.5 Merck Recent Development
    • 12.5 Agilent Technologies
      • 12.5.1 Agilent Technologies Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 In situ Hybridization Introduction
      • 12.5.4 Agilent Technologies Revenue in In situ Hybridization Business (2014-2019)
      • 12.5.5 Agilent Technologies Recent Development
    • 12.6 Perkin Elmer
      • 12.6.1 Perkin Elmer Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 In situ Hybridization Introduction
      • 12.6.4 Perkin Elmer Revenue in In situ Hybridization Business (2014-2019)
      • 12.6.5 Perkin Elmer Recent Development
    • 12.7 Danaher
      • 12.7.1 Danaher Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 In situ Hybridization Introduction
      • 12.7.4 Danaher Revenue in In situ Hybridization Business (2014-2019)
      • 12.7.5 Danaher Recent Development
    • 12.8 Exiqon
      • 12.8.1 Exiqon Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 In situ Hybridization Introduction
      • 12.8.4 Exiqon Revenue in In situ Hybridization Business (2014-2019)
      • 12.8.5 Exiqon Recent Development
    • 12.9 Biogenex Laboratories
      • 12.9.1 Biogenex Laboratories Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 In situ Hybridization Introduction
      • 12.9.4 Biogenex Laboratories Revenue in In situ Hybridization Business (2014-2019)
      • 12.9.5 Biogenex Laboratories Recent Development
    • 12.10 Advanced Cell Diagnostics
      • 12.10.1 Advanced Cell Diagnostics Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 In situ Hybridization Introduction
      • 12.10.4 Advanced Cell Diagnostics Revenue in In situ Hybridization Business (2014-2019)
      • 12.10.5 Advanced Cell Diagnostics Recent Development
    • 12.11 Bio Sb

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      In situ hybridization (ISH) is a type of hybridization that uses a labeled complementary DNA, RNA or modified nucleic acids strand to localize a specific DNA or RNA sequence in a portion or section of tissue (in situ), or, if the tissue is small enough, in the entire tissue, in cells, and in circulating tumor cells (CTCs). This is distinct from immunohistochemistry, which usually localizes proteins in tissue sections.
      North America is expected to account for the largest share of the market in 2018. This can be attributed to growing clinical and research in cancer by biotechnology and pharmaceutical companies, government initiatives, increasing prevalence and diagnosis of cancer in the U.S. and Canada, and increasing adoption of companion diagnostics. Increased adoption of companion diagnostics is attributed to the development and launch of newer therapeutic agents. However, the Asia-Pacific region is expected to grow at the highest CAGR during the forecast period. This can be attributed to the growing presence of international players in China and India, increasing cancer prevalence and diagnosis, and increased healthcare expenditure across the Asia-Pacific region are drivers for the in situ hybridization market in this region.
      In 2018, the global In situ Hybridization market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global In situ Hybridization status, future forecast, growth opportunity, key market and key players. The study objectives are to present the In situ Hybridization development in United States, Europe and China.

      The key players covered in this study
      Abbott Laboratories
      Roche
      Thermo Fisher Scientific
      Merck
      Agilent Technologies
      Perkin Elmer
      Danaher
      Exiqon
      Biogenex Laboratories
      Advanced Cell Diagnostics
      Bio Sb

      Market segment by Type, the product can be split into
      Fluorescence In Situ Hybridization (FISH)
      Chromogenic In Situ Hybridization

      Market segment by Application, split into
      Cancer Diagnosis
      Immunology
      Neuroscience
      Cytology
      Infectious Diseases

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global In situ Hybridization status, future forecast, growth opportunity, key market and key players.
      To present the In situ Hybridization development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of In situ Hybridization are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now